Saline enhanced needle ablation for stubborn heart rhythm
Part of Heart & circulation clinical trials.
This trial studies a special “needle” ablation method (with saline) to treat a dangerous, repeat heart rhythm problem called monomorphic ventricular tachycardia (VT). It’s for adults whose VT keeps coming back despite prior treatments and who may not benefit from another standard ablation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart disease in addition to the abnormal rhythm (structural heart disease)
- You are 18 years or older and can sign consent
- You’ve had repeated, symptom-causing sustained VT (lasting over 30 seconds) in the last 180 days
- Your VT was treated with anti-tachycardia pacing and/or shocks, and it kept coming back after prior catheter ablation
- You have an ICD (defibrillator) with at least 6 months of device data showing VT episodes
- Your treating team believes you may not benefit from another conventional ablation method
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special navigation technique to improve the success of repeat catheter ablation for ventricular arrhythmias, helping patients who haven't been helped by prior procedures or medications.
This study tests a new catheter-based treatment for people with certain types of very fast or extra heartbeats that come from the lower chambers of the heart. The catheter uses a special energy to stop the abnormal beats and might help if you have had symptoms despite other treatments.
This study compares two catheter-based procedures to treat ventricular tachycardia (VT), a fast, dangerous heart rhythm. It looks to see which approach works better at reducing repeat VT events in people with weakened heart pumping.
This trial studies a radiation approach (called stereotactic body radiation therapy, or SBRT) to treat ventricular tachycardia (a dangerous heart rhythm) that keeps coming back. It aims to reduce the rhythm episodes in people who have already tried catheter ablation (a procedure to cauterize rhythm sources) or cannot have it.
This trial tests a new catheter-based procedure to treat life-threatening irregular heartbeats (ventricular tachycardia) that keep coming back despite medication. If you've had a heart attack and your implanted defibrillator hasn't fully controlled these arrhythmias, this procedure might help prevent future episodes.
This trial tests a freezing catheter procedure to treat dangerous, recurring abnormal heart rhythms (ventricular tachycardia) in patients whose hearts are weakened and whose current medications haven't worked. The procedure aims to scar the tissue causing the arrhythmia so your heart beats normally again.
Hear when a new Refractory Ventricular Tachycardia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.